64B3-2.003: Definitions
PURPOSE AND EFFECT: The Board proposes an amendment that will define and specify that experience acquired as a part of a training program may not be used as pertinent clinical laboratory experience.
SUMMARY: The proposed rule amendment will define and specify that experience acquired as a part of a training program may not be used as pertinent clinical laboratory experience.
SUMMARY OF ESTIMATED REGULATORY COSTS: No Statement of Estimated Regulatory Cost was prepared.
Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.
SPECIFIC AUTHORITY: 483.805(4), 483.811(2) FS.
LAW IMPLEMENTED: 483.803, 483.811, 483.821, 483.823 FS.
IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN FAW.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Joe Baker, Jr., Executive Director, Board of Clinical Laboratory Personnel, 4052 Bald Cypress Way, Bin # C07, Tallahassee, Florida 32399-3257.
THE FULL TEXT OF THE PROPOSED RULE IS:
64B3-2.003 Definitions.
(1) - (7) No change.
(8) Pertinent clinical laboratory experience is experience in a clinical laboratory as defined in Section 483.041(2), Florida Statutes. If acquired in-state or in a state where licensure is required, experience must be accrued while licensed and working in a licensed laboratory unless otherwise authorized by the administrative rules of this Board. Experience acquired as a part of a training program may not be used as pertinent clinical laboratory experience. Exempt experience may not be utilized with the exception of experience in federal laboratories. Experience in industrial laboratories is not considered pertinent clinical laboratory experience. Experience in research laboratories is not considered pertinent clinical laboratory experience unless the research experience involved human subjects and used methodologies, quality control and quality assurance techniques comparable to those of clinical laboratories. If all of these requirements are met the Board will review the research experience to determine if it is relevant experience. If research experience was acquired under an exemption clause, it may not be utilized as pertinent clinical laboratory experience. Experience acquired in an exclusive use laboratory environment, waived laboratory environment or alternate site testing environment is generally unacceptable unless specifically authorized by rules of this Board.
(9) - (19) No change.
Specific Authority 483.805(4), 483.811(2) FS.
Law Implemented 483.803, 483.811, 483.821, 483.823 FS.
